RECRUITING

Implementing Contingency Management for Stimulant Use in Specialty Addiction Treatment Organizations

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Stimulants constitute a new and deadly fourth wave of the opioid epidemic. Contingency management is the most effective intervention for stimulant use and is an evidence-based adjunct to medication for opioid use disorder. Yet, uptake of contingency management in opioid treatment programs that provide medication for opioid use disorder remains low; in fact, access to contingency management is arguably one of the greatest research-to-practice gaps in the addiction treatment services field. The goal of this study is to conduct a type III hybrid effectiveness-implementation trial to evaluate a multi-level implementation strategy, the Science of Service Laboratory, to install contingency management for stimulant use in opioid treatment programs. The Science of Service Laboratory has three core components: didactic training, performance feedback, and external facilitation. Utilizing a stepped wedge design, a regional cohort of 10 public sector opioid treatment programs will be randomized to receive Science of Service Laboratory at five distinct time points. At six intervals, each of the 10 opioid treatment programs will provide de-identified electronic medical record data from all available patient charts on contingency management delivery and patient outcomes. Staff from each opioid treatment program will provide feedback on contextual determinants influencing implementation. This study will rigorously evaluate whether a multi-level implementation strategy developed by one of the longest-standing national intermediary purveyor organizations-the SAMHSA Technology Transfer Centers, will improve both implementation and patient outcomes.

Official Title

Implementing Contingency Management for Stimulant Use in Specialty Addiction Treatment Organizations (Center for Dissemination and Implementation Science at Stanford, Research Component #2)

Quick Facts

Study Start:2023-06-07
Study Completion:2027-08-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05702021

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. *
  1. * Persons on Medication for Opioid Use Disorder \[Not recruited, via electronic medical records only\]
  2. *

Contacts and Locations

Study Contact

Medical Director of Behavioral Health Chicago Department of Pu
CONTACT
312-742-0381
miao.hua@cityofchicago.org

Principal Investigator

Sara Becker
PRINCIPAL_INVESTIGATOR
Northwestern University

Study Locations (Sites)

Lawndale Christian Health Center
Chicago, Illinois, 60623
United States
Healthcare Alternative Systems NEXA-MAR
Chicago, Illinois, 60651
United States
Community Outreach Intervention Projects Southside Mobile Van
Chicago, Illinois, 60654
United States
Family Guidance Centers Chicago Ave.
Chicago, Illinois, 60654
United States
Addiction Recovery Institute
Pawtucket, Rhode Island, 02860
United States
CODAC Pawtucket
Pawtucket, Rhode Island, 02860
United States
Providence Comprehensive Treatment Center
Providence, Rhode Island, 02905
United States
VICTA
Providence, Rhode Island, 02907
United States
CODAC Providence
Providence, Rhode Island, 02909
United States
Woonsocket Comprehensive Treatment Center
Woonsocket, Rhode Island, 02895
United States

Collaborators and Investigators

Sponsor: Northwestern University

  • Sara Becker, PRINCIPAL_INVESTIGATOR, Northwestern University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-06-07
Study Completion Date2027-08-01

Study Record Updates

Study Start Date2023-06-07
Study Completion Date2027-08-01

Terms related to this study

Keywords Provided by Researchers

  • Stimulants
  • Contingency management
  • Opioid Use Disorder
  • Implementation science
  • Behavior change

Additional Relevant MeSH Terms

  • Stimulant Use (Diagnosis)